NASDAQ:ADUS

Addus HomeCare Stock Forecast, Price & News

$86.79
+2.98 (+3.56 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$83.23
$86.80
50-Day Range
$80.75
$96.17
52-Week Range
$80.32
$129.01
Volume129,366 shs
Average Volume104,438 shs
Market Capitalization$1.38 billion
P/E Ratio41.73
Dividend YieldN/A
Beta0.7
30 days | 90 days | 365 days | Advanced Chart
Receive ADUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.


Addus HomeCare logo

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of March 9, 2021, the company served consumers through 212 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.39 out of 5 stars

Medical Sector

1053rd out of 2,216 stocks

Home Health Care Services Industry

9th out of 12 stocks

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Addus HomeCare (NASDAQ:ADUS) Frequently Asked Questions

Is Addus HomeCare a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Addus HomeCare stock.
View analyst ratings for Addus HomeCare
or view top-rated stocks.

What stocks does MarketBeat like better than Addus HomeCare?

Wall Street analysts have given Addus HomeCare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Addus HomeCare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Addus HomeCare?

Addus HomeCare saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 356,400 shares, an increase of 24.4% from the June 30th total of 286,500 shares. Based on an average daily volume of 124,000 shares, the days-to-cover ratio is presently 2.9 days. Approximately 2.3% of the shares of the company are short sold.
View Addus HomeCare's Short Interest
.

When is Addus HomeCare's next earnings date?

Addus HomeCare is scheduled to release its next quarterly earnings announcement on Monday, August 2nd 2021.
View our earnings forecast for Addus HomeCare
.

How can I listen to Addus HomeCare's earnings call?

Addus HomeCare will be holding an earnings conference call on Tuesday, August 3rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "4489483".

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) posted its earnings results on Sunday, May, 2nd. The company reported $0.74 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.74. The firm had revenue of $205.30 million for the quarter, compared to analyst estimates of $209.70 million. Addus HomeCare had a net margin of 4.28% and a trailing twelve-month return on equity of 8.50%. The company's quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.77 EPS.
View Addus HomeCare's earnings history
.

How has Addus HomeCare's stock been impacted by COVID-19?

Addus HomeCare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ADUS stock has increased by 28.3% and is now trading at $86.79.
View which stocks have been most impacted by COVID-19
.

Who are Addus HomeCare's key executives?

Addus HomeCare's management team includes the following people:
  • Mr. R. Dirk Allison, CEO & Chairman (Age 65, Pay $1.58M)
  • Mr. W. Bradley Bickham, Pres & COO (Age 58, Pay $837.71k)
  • Mr. Brian W. Poff, CFO, Exec. VP, Sec. & Treasurer (Age 47, Pay $772.27k)
  • Mr. Sean P. Gaffney, Exec. VP & Chief Legal Officer (Age 41, Pay $611.3k) (LinkedIn Profile)
  • Mr. Darby Anderson, Exec. VP & Chief Strategy Officer (Age 55, Pay $684.87k)
  • Ms. Monica Raines, Sr. VP & Chief Compliance Officer
  • Mr. David W. Tucker, Exec. VP & Chief Devel. Officer (Age 56) (LinkedIn Profile)
  • Mr. Robby James Stevenson, Exec. VP & Chief Human Resource Officer
  • Ms. Diane Kumarich, Sr. VP of National Contracts & Bus. Devel.
  • Mr. Paul Akin, Sr. VP of Project Management & Integration

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare CEO Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among Addus HomeCare's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Addus HomeCare's key competitors?

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and The Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by many different institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.07%). Company insiders that own Addus HomeCare stock include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham.
View institutional ownership trends for Addus HomeCare
.

Which major investors are buying Addus HomeCare stock?

ADUS stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue.
View insider buying and selling activity for Addus HomeCare
or or view top insider-buying stocks.

How do I buy shares of Addus HomeCare?

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $86.79.

How much money does Addus HomeCare make?

Addus HomeCare has a market capitalization of $1.38 billion and generates $764.78 million in revenue each year. The company earns $33.13 million in net income (profit) each year or $2.79 on an earnings per share basis.

How many employees does Addus HomeCare have?

Addus HomeCare employs 35,139 workers across the globe.

What is Addus HomeCare's official website?

The official website for Addus HomeCare is www.addus.com.

Where are Addus HomeCare's headquarters?

Addus HomeCare is headquartered at 6801 GAYLORD PARKWAY, FRISCO TX, 75034.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]


This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.